Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.
Open | $22.650 |
Close | - |
Volume / Avg. | 82.149K / 692.953K |
Day Range | 22.610 - 23.050 |
52 Wk Range | 14.890 - 32.525 |
Market Cap | $2.053B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 23.06% |
Days to Cover | 13.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rocket Pharmaceuticals (NASDAQ: RCKT) through any online brokerage.
Other companies in Rocket Pharmaceuticals’s space includes: MoonLake (NASDAQ:MLTX), Fusion Pharmaceuticals (NASDAQ:FUSN), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO) and Inhibrx (NASDAQ:INBX).
The latest price target for Rocket Pharmaceuticals (NASDAQ: RCKT) was reported by Needham on Tuesday, May 7, 2024. The analyst firm set a price target for 53.00 expecting RCKT to rise to within 12 months (a possible 134.41% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $22.61 last updated Today at May 21, 2024 at 11:52 AM EDT.
There are no upcoming dividends for Rocket Pharmaceuticals.
Rocket Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Rocket Pharmaceuticals.
Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.